PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (Nasdaq: BJGP) today announced that it has reached agreement with Lotus Healthcare Inc. (“Lotus”) to promote and sell Lotus’ prescription analgesic Galake™ (dihydrocodeine 10mg/paracetamol 500 mg) in the People’s Republic of China.
